1-20 of 24
Authors: Santiago Moreno
Journal Article
Real-world efficacy and tolerability of CAB+RPV LA in women: addressing the gender gap in HIV treatment research Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 4, April 2025, Pages 1084–1088, https://doi.org/10.1093/jac/dkaf038
Published: 11 February 2025
Journal Article
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 682–691, https://doi.org/10.1093/jac/dkae456
Published: 23 December 2024
Journal Article
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1423–1432, https://doi.org/10.1093/jac/dkad102
Published: 26 April 2023
Journal Article
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 3, March 2023, Pages 823–827, https://doi.org/10.1093/jac/dkad019
Published: 01 February 2023
Journal Article
Redefining therapeutic success in HIV patients: an expert view
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 10, October 2021, Pages 2501–2518, https://doi.org/10.1093/jac/dkab168
Published: 02 June 2021
Journal Article
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 10, October 2020, Pages 3004–3014, https://doi.org/10.1093/jac/dkaa246
Published: 15 July 2020
Journal Article
Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the CNICS cohort
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 6, June 2020, Pages 1604–1610, https://doi.org/10.1093/jac/dkaa024
Published: 24 March 2020
Journal Article
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1294–1300, https://doi.org/10.1093/jac/dkaa009
Published: 06 February 2020
Journal Article
Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 235–239, https://doi.org/10.1093/jac/dkw375
Published: 21 September 2016
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 11, November 2015, Pages 3087–3095, https://doi.org/10.1093/jac/dkv205
Published: 30 July 2015
Journal Article
Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 2, February 2015, Pages 630–632, https://doi.org/10.1093/jac/dku402
Published: 09 October 2014
Journal Article
Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 7, July 2014, Pages 1916–1919, https://doi.org/10.1093/jac/dku059
Published: 12 March 2014
Journal Article
Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C) Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 2, February 2014, Pages 471–475, https://doi.org/10.1093/jac/dkt386
Published: 04 October 2013
Journal Article
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens Get access
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 6, June 2012, Pages 1462–1469, https://doi.org/10.1093/jac/dks080
Published: 19 March 2012
Journal Article
Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials Get access
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 2, February 2012, Pages 312–321, https://doi.org/10.1093/jac/dkr478
Published: 29 November 2011
Journal Article
The future of antiretroviral therapy: challenges and needs Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 5, May 2010, Pages 827–835, https://doi.org/10.1093/jac/dkq061
Published: 12 March 2010
Journal Article
Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis Get access
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 6, December 2009, Pages 1139–1147, https://doi.org/10.1093/jac/dkp357
Published: 09 October 2009
Journal Article
The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy Get access
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 2, August 2008, Pages 234–245, https://doi.org/10.1093/jac/dkn191
Published: 14 May 2008
Journal Article
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 61, Issue 1, January 2008, Pages 206–209, https://doi.org/10.1093/jac/dkm438
Published: 13 November 2007
